Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.15.557794Source: DataRank Database

Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0.607. It has been cited 12 times, with 11 citing works in its 1-hop citation network.

N/A

0.607DataRank · unranked

Scored on demand from live citation data

Open Access12 citations · 11 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)OA: greenTopics (13)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 63%Citation Network 37%

Base Score Contribution

0.385

From this paper's citation signal

Citation Network Contribution

0.222

From 6 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 11 citers.

A Case of Immune-Related Adverse Events, Including Myasthenia Gravis, Myositis, and Myocarditis, during Avelumab and Axitinib Combination Therapy
Case Reports in Oncology20253 citations12 referencesContributes 0.116
Engineered platelet-derived exosomal spheres for enhanced tumor penetration and extended circulation in melanoma immunotherapy
Acta Pharmaceutica Sinica B20259 citations34 referencesContributes 0.068
4E-BP3 deficiency impairs dendritic cell activation and CD4+ T cell differentiation and attenuates α-myosin-specific T cell-mediated myocarditis in mice
Basic Research in Cardiology20249 citations60 referencesContributes 0.038
Molecular mechanisms and therapies of immune checkpoint inhibitor associated myocarditis: Update on recent developments
Seminars in Cancer Biology20258 citations118 referencesContributes 0.019
To investigate the causal relationship between immune cell phenotype, blood metabolites, and myocarditis in a Mendelian randomization study
Medicine20251 citations42 referencesContributes 0.017

Authors (36)

Daniel A. Zlotoff ORCID,Neal P. Smith ORCID,Isabela Kernin ORCID,Swetha Ramesh ORCID,Leyre Zubiri ORCID

Live enrichment

PubMed:37790460 OpenAlex:https://openalex.org/W4386819396

National Institutes of Health

Grant: 5K08DK127246-04

Unraveling the Role of PD-1 in CD8+ Tissue-Resident Memory T Cell Homeostasis and Epithelial Damage in Human Colitis

National Institutes of Health

Grant: 2T32AR007258-46

Research Training in Rheumatology at Massachusetts General Hospital

National Institutes of Health

Grant: 5T32CA071345-08

Training Program in Cancer Biology

National Institutes of Health

Grant: 2T32CA071345-21A1

Training Program in Cancer Biology and Therapeutics

National Institutes of Health

Grant: 1DP2CA247831-01

Deciphering the Achilles Heel of Cancer Immunotherapy

National Institutes of Health

Grant: 5K24HL150238-05

Cardiovascular Diseases among Patients with Cancer and Patients living with HIV

National Institutes of Health

Grant: 3K08HL157725-03S1

High-dimensional single-cell mapping to define immune signatures of cytomegalovirus-associated rejection in cardiac transplantation

National Institutes of Health

Grant: 5R01HL130539-04

STOP-CA: Statins to prevent Cardiotoxicity from Anthracyclines

National Institutes of Health

Grant: 1R01HL137562-01A1

Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins

National Institutes of Health

Grant: 5T32HL007208-38

Cell & Molecular Training for Cardiovascular Biology

NIDDK NIH HHS

Grant: K08 DK127246

NHLBI NIH HHS

Grant: K24 HL150238

NHLBI NIH HHS

Grant: R01 HL137562

NHLBI NIH HHS

Grant: T32 HL007208

NHLBI NIH HHS

Grant: K08 HL157725

NCI NIH HHS

Grant: DP2 CA247831

NIDDK NIH HHS

Grant: P30 DK043351

NIAMS NIH HHS

Grant: T32 AR007258

NHLBI NIH HHS

Grant: R01 HL130539

NCI NIH HHS

Grant: T32 CA071345

greenLicense: cc-by

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/09/18/2023.09.15.557794.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.09.15.557794

repositoryhttps://doi.org/10.1101/2023.09.15.557794

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37790460

Fields of Study

Viral Infections and Immunology ResearchImmune Cell Function and InteractionCytokine Signaling Pathways and Interactions03 medical and health sciences0302 clinical medicine

Keywords

MyocarditisImmune systemMedicineImmune checkpointImmunologyInternal medicineImmunotherapyArticle

Sustainable Development Goals

SDG 0: Good health and well-being